XRCC1 Gene Polymorphisms and the Risk of Differentiated Thyroid Carcinoma (DTC): a Meta-analysis of Case-control Studies

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 May 30

PMID 23717668

Citations 7

Authors

Yi Bao

Lei Jiang

Jue-Yu Zhou

Jun-Jie Zou

Jiao-Yang Zheng

Xiang-Fang Chen

Zhi-Min Liu

Yong-Quan Shi

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies investigating the association between X-ray repair cross-complementing group 1 (XRCC1) polymorphisms and thyroid cancer risk have yielded inconsistent results. This meta-analysis was performed to derive a more precise estimation of the relationship between three XRCC1 polymorphisms and thyroid cancer risk.

Methods/principal Findings: PubMed and EMBASE database were systematically searched to identify relevant studies. 10 publications were selected for this meta-analysis, including 11 studies for Arg399Gln polymorphism (1726 cases and 3774 controls), 7 studies for Arg194Trp polymorphism (1037 cases and 2487 controls) and 8 studies for Arg280His polymorphism (1432 cases and 3356 controls). The results in total population did not show any significant association between these three polymorphisms and the risk of DTC for all genetic models. However, when stratified by ethnicity, the results showed that Arg280His polymorphism was associated with an increased risk of DTC among Caucasians (Arg/His vs. Arg/Arg: OR = 1.45, 95% CI = 1.09-1.93; dominant model: OR = 1.43, 95% CI = 1.08-1.89; additive model: OR = 1.38, 95% CI = 1.05-1.80), whereas individuals carrying Arg/His genotype have a significantly reduced risk of DTC among Asians (Arg/His vs. Arg/Arg: OR = 0.71, 95% CI = 0.51-0.98). We also detected that 399Gln variant allele carriers might presented an overall decreased risk of DTC in mixed population. Furthermore, subgroup analyses by histological subtype revealed that Arg194Trp polymorphism was significantly associated with reduced risk for papillary thyroid carcinoma (PTC) (dominant model: OR = 0.71, 95% CI = 0.50-0.99).

Conclusions: This meta-analysis suggests that Arg280His polymorphism might contribute to the susceptibility of DTC among Caucasians, whereas it might provide protective effects in Asians against the risk of DTC. Additionally, our results support the protective role of Arg194Trp polymorphism in developing PTC, and show evidence of an association between Arg399Gln polymorphism and decreased risk of DTC in mixed population.

Citing Articles

Identification of crucial genes involved in thyroid cancer development.

Kalarani I, Sivamani G, Veerabathiran R J Egypt Natl Canc Inst. 2023; 35(1):15.

PMID: 37211566 DOI: 10.1186/s43046-023-00177-0.

Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications.

Liu M, Qiu Z, Yang Q Comput Math Methods Med. 2022; 2022:9988513.

PMID: 36277013 PMC: 9586779. DOI: 10.1155/2022/9988513.

GA Genotype of the Arg280His Polymorphism on The Gene: Genetic Susceptibility Genotype in Differentiated Thyroid Carcinomas?.

Kirnap N, Tutuncu N, Yalcin Y, Cebi H, Tutuncu T, Nar A Balkan J Med Genet. 2021; 24(1):73-80.

PMID: 34447662 PMC: 8366467. DOI: 10.2478/bjmg-2021-0003.

Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance.

Dong Y, Vadla G, Lu J, Ahmad V, Klein T, Liu L Commun Biol. 2021; 4(1):374.

PMID: 33742110 PMC: 7979758. DOI: 10.1038/s42003-021-01898-5.

Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma.

Mei P, Bai J, Miao F, Li Z, Chen C, Zheng J Invest New Drugs. 2018; 37(4):646-657.

PMID: 30328556 DOI: 10.1007/s10637-018-0667-9.

References

S Santos L, Branco S, Silva S, Azevedo A, M Gil O, Manita I . Polymorphisms in base excision repair genes and thyroid cancer risk. Oncol Rep. 2012; 28(5):1859-68. DOI: 10.3892/or.2012.1975. View

Wang Y, Yang H, Li H, Li L, Wang H, Liu C . Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009; 285(2):134-40. DOI: 10.1016/j.canlet.2009.05.005. View

Chacko P, Rajan B, Joseph T, Mathew B, Pillai M . Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat. 2005; 89(1):15-21. DOI: 10.1007/s10549-004-1004-x. View

Xiong P, Zheng R, Wang L, Bondy M, Shen H, Borer M . A pilot case-control study of gamma-radiation sensitivity and risk of papillary thyroid cancer. Thyroid. 2005; 15(2):94-9. DOI: 10.1089/thy.2005.15.94. View

Wang L, Yin F, Xu X, Hu X, Zhao D . X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. PLoS One. 2012; 7(4):e34897. PMC: 3329555. DOI: 10.1371/journal.pone.0034897. View

Goode E, Ulrich C, Potter J . Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002; 11(12):1513-30. View

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

Shen M, Jones I, Mohrenweiser H . Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998; 58(4):604-8. View

Zhu Q, Bian J, Shen Q, Jiang F, Tang H, Zhang H . [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8):702-5. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Wallace S, Murphy D, Sweasy J . Base excision repair and cancer. Cancer Lett. 2012; 327(1-2):73-89. PMC: 3361536. DOI: 10.1016/j.canlet.2011.12.038. View

12.

Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O . RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest. 2008; 31(10):893-9. DOI: 10.1007/BF03346438. View

13.

Wood R, Mitchell M, Sgouros J, Lindahl T . Human DNA repair genes. Science. 2001; 291(5507):1284-9. DOI: 10.1126/science.1056154. View

14.

Chen A, Jemal A, Ward E . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801-7. DOI: 10.1002/cncr.24416. View

15.

Garcia-Quispes W, Perez-Machado G, Akdi A, Pastor S, Galofre P, Biarnes F . Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res. 2011; 709-710:67-72. DOI: 10.1016/j.mrfmmm.2011.03.003. View

16.

Neta G, Brenner A, Sturgis E, Pfeiffer R, Hutchinson A, Aschebrook-Kilfoy B . Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis. 2011; 32(8):1231-7. PMC: 3166197. DOI: 10.1093/carcin/bgr100. View

17.

Ryu R, Tae K, Min H, Jeong J, Cho S, Lee S . XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8):991-5. PMC: 3154355. DOI: 10.3346/jkms.2011.26.8.991. View

18.

Tronko M, Howe G, Bogdanova T, Bouville A, Epstein O, Brill A . A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst. 2006; 98(13):897-903. DOI: 10.1093/jnci/djj244. View

19.

Dai L, Duan F, Wang P, Song C, Wang K, Zhang J . XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012; 39(10):9535-47. DOI: 10.1007/s11033-012-1818-2. View

20.

Li Y, Liu F, Tan S, Wang Y, Li S . X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. PLoS One. 2012; 7(9):e44441. PMC: 3440401. DOI: 10.1371/journal.pone.0044441. View